(Q36106773)

12 August 2017

1 reference

title

Executive dysfunction in major depressive disorder (English)

1 reference

12 August 2017

main subject

executive disfunction

1 reference

Charles DeBattista

1

1 reference

12 August 2017

publication date

1 January 2005

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

published in

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

79-83

1 reference

Executive functions and their disorders

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Cognitive deficits in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Neuropsychological function in young patients with unipolar major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Executive function in depression: the role of performance strategies in aiding depressed and non-depressed participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Cognitive function in depression: a distinct pattern of frontal impairment in melancholia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Executive deficits in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Executive functions and P300 latency in elderly depressed patients and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Symptoms of striatofrontal dysfunction contribute to disability in geriatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Executive dysfunction in geriatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Executive dysfunction and long-term outcomes of geriatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Prefrontal dysfunction and treatment response in geriatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Modafinil in children with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

A prospective trial of modafinil as an adjunctive treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Attention deficit hyperactivity disorder, combined type: better executive function performance with longer-term psychostimulant medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

Neuropsychological evidence for frontostriatal dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.79

21 January 2018

Identifiers

DOI

10.1586/14737175.5.1.79

1 reference

12 August 2017

1 reference